Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03097978 · ClinicalTrials.gov registry record · NA
Comparison of Pattern Recognition Control and Direct Control in TMR
A NA study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03097978: Completed NA study, sponsored by Shirley Ryan AbilityLab.
NCT03097978 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03097978, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Targeted Muscle Reinnervation increases the control signals available for commercial arm systems. A new type of control, pattern recognition, has been developed into a form that allows use with commercially available arm system. The goal of this project is a home trial, in which people who have had TMR will try the new controls and the new arm to find out if they are better than what is currently available. Home trials will also allow us to see what needs to be done to make our inventions work even better.
Primary Outcome
Improved control of prosthesis as seen through functional use improvements.
Interventions
- DEVICE Commercial system
- DEVICE RIC arm system
- OTHER Direct Control
- OTHER Pattern Recognition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-06 |
| Est. Completion | 2017-09-29 |
| Phase | NA |
What the finished NCT03097978 record still lists
NCT03097978 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Commercial system is the first listed.
NCT03097978 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03097978 about?
NCT03097978 is a clinical study titled "Comparison of Pattern Recognition Control and Direct Control in TMR". Targeted Muscle Reinnervation increases the control signals available for commercial arm systems. A new type of control, pattern recognition, has been developed into a form that allows use with commercially available arm system. The goal of this project is a home trial, in which people who have had ...
What is the current status of trial NCT03097978?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2013-06. Estimated completion is 2017-09-29.
What interventions are being tested in trial NCT03097978?
The interventions under investigation include: Commercial system (DEVICE), RIC arm system (DEVICE), Direct Control (OTHER), Pattern Recognition (OTHER).
Who is sponsoring clinical trial NCT03097978?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03097978's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia